alkaloidal immunosuppresants (C-TRI)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namealkaloidal immunosuppresants (C-TRI)
Drug Alias NameCT-20202CT-20204
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A